Research ArticleNEUROPHARMACOLOGY
S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole
Mark J. Millan, Mauricette Brocco, Mariusz Papp, Florence Serres, Christophe Drieu La Rochelle, Trevor Sharp, Jean-Louis Peglion and Anne Dekeyne
Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 936-950; DOI: https://doi.org/10.1124/jpet.103.062463
Mark J. Millan
Mauricette Brocco
Mariusz Papp
Florence Serres
Christophe Drieu La Rochelle
Trevor Sharp
Jean-Louis Peglion
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 309, Issue 3
1 Jun 2004
Research ArticleNEUROPHARMACOLOGY
S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole
Mark J. Millan, Mauricette Brocco, Mariusz Papp, Florence Serres, Christophe Drieu La Rochelle, Trevor Sharp, Jean-Louis Peglion and Anne Dekeyne
Journal of Pharmacology and Experimental Therapeutics June 1, 2004, 309 (3) 936-950; DOI: https://doi.org/10.1124/jpet.103.062463
Research ArticleNEUROPHARMACOLOGY
S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole
Mark J. Millan, Mauricette Brocco, Mariusz Papp, Florence Serres, Christophe Drieu La Rochelle, Trevor Sharp, Jean-Louis Peglion and Anne Dekeyne
Journal of Pharmacology and Experimental Therapeutics June 1, 2004, 309 (3) 936-950; DOI: https://doi.org/10.1124/jpet.103.062463
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement